Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis (TARGET Trial): Does Ticagrelor Improve Graft Patency After Coronary Bypass?
Phase of Trial: Phase IV
Latest Information Update: 21 Jul 2016
At a glance
- Drugs Ticagrelor (Primary) ; Aspirin
- Indications Coronary artery disease; Coronary artery restenosis; Vascular graft occlusion
- Focus Therapeutic Use
- Acronyms TARGET
- 18 Jul 2016 Planned End Date changed from 1 Sep 2018 to 1 Jun 2020.
- 18 Jul 2016 Planned primary completion date changed from 1 Sep 2018 to 1 Jun 2019.
- 24 Sep 2014 Planned End Date changed from 1 Apr 2018 to 1 Sep 2018 as reported by ClinicalTrials.gov.